Status:
SUSPENDED
Wheelchair Provision Time for Hospital Inpatients
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Wheelchairs
Eligibility:
All Genders
Brief Summary
In a Pilot Study, the median Wheelchair Lead Time (from when a wheelchair was ordered by an Occupational Therapist for an inpatient in the Central Zone of Nova Scotia Health to when the wheelchair arr...
Detailed Description
The wheelchair provision process within the Central Zone of Nova Scotia Health includes the ordering, assembly, and delivery of wheelchairs from where the inventory is stored at the Nova Scotia Rehabi...
Eligibility Criteria
Inclusion
- to have been an inpatient in a Central Zone hospital site during the 11-weekday study period in late January 2023
- , to have had a WheelEase order placed during the 11-weekday study period in late January 2023
- to have had a Wheelchair Delivery Time recorded
- to have been subsequently discharged from a Central Zone hospital site.
Exclusion
- if the WheelEase order was cancelled before delivery.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT06566040
Start Date
October 1 2024
End Date
June 1 2026
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada, B3H4K4